CAMP4 Therapeutics Corporation

NASDAQ:CAMP

Biotechnology

Healthcare
$4.10 +2.42%

+$0.10 today

Market cap
$257.29M
Beta
0.08
P/E (TTM)
-2.8
EPS (TTM)
-$1.49
52W Low $1.31High $7.75

Volume 0.19M

Average 0.10M

CAMP Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

CAMP4 Therapeutics CorporationNASDAQ: CAMP

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital dips below year-ago levels

Q1 FY2026 change in working capital of $865K (cash outflow) fell 75.4% year over year, behind the +501.8% change in trailing-twelve-month change in working capital.

Context

  • Change in working capital amounted to 371.9% of revenue in FY2025, up 82.9 pp from a year earlier.
  • Change in working capital increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -75.4% toward the trailing-twelve-month pace of +501.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$865K-105.2% QoQ
Last fiscal yearDec 2025
$13.01M+790.4% YoY
LTMMar 2026
$16.05M+501.8% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-75.4%——
1 year+790.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
13.01M USD
Year-over-year change
+790.4%
4-year CAGR
+69.1%

Change in Working Capital vs competitors

How CAMP compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +501.8% is the 2nd highest of 9, against a peer median of -59.7%.
  • Change in working capital amounts to 408.1% of revenue for CAMP, versus a peer median of 16.9%.
CAMP Competitors
Change in Working Capital for CAMP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VXRTVaxart, Inc.LTM Mar 2026$35.96M USD-1082.5%+68.7%14.1%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$16.05M USD+501.8%—408.1%
ATYRaTyr Pharma, Inc.LTM Mar 2026$5.86M USD+748.8%—3083.7%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$3.95M USD+22.3%-67.6%—
BMEABiomea Fusion, Inc.LTM Mar 2026$3.84M USD-41.3%——
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$3.32M USD-11.9%——
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$3.1M CAD-409.0%-21.9%16.9%
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 2026$3.08M USD-227.9%+16.6%—
PMVPPMV Pharmaceuticals, Inc.LTM Mar 2026$208K USD-78.2%——
Peer median (excluding CAMP) —-59.7%-2.7%16.9%

Competitors are the stored peer set for CAMP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Feb 2022
FY2022
Feb 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.99M)(44.19M)(49.29M)(51.79M)(80.4M)
Depreciation & Amortization22.8M878K1.68M1.7M1.64M
Deferred Income Tax00000
Stock-Based Compensation11.32M1.38M2.91M4.03M4M
Change in Working Capital1.59M373K(154K)(1.88M)13.01M
Accounts Receivables1.44M0000
Inventory5.16M0000
Accounts Payables0000(1.03M)
Other Working Capital(5.01M)373K(154K)(1.88M)14.04M
Other Non-Cash Items(11.94M)3.02M705K2.39M32.21M
Operating Cash Flow(4.22M)(38.54M)(44.16M)(45.56M)(29.55M)
Capital Expenditures(13.3M)(4.03M)(678K)(441K)(279K)
Acquisitions (Net)000036K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities5.72M0000
Investing Cash Flow(7.58M)(4.03M)(678K)(441K)(243K)
Debt Repayment—(93K)116K(824K)(208K)
Common Stock Issued000061.17M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(2.64M)100.25M185K72.49M14.93M
Financing Cash Flow(2.64M)100.16M301K71.66M75.89M
Effect of Forex Changes(965K)25.6M000
Net Change in Cash(15.4M)83.19M(44.53M)25.66M46.09M
Free Cash Flow(17.52M)(42.57M)(44.83M)(46M)(29.83M)

CAMP4 Therapeutics Corporation

NASDAQ:CAMP

Intrinsic Alpha fair value

Locked

Current Price

$4.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.